First preliminary results of a single case report: Duloxetine might improve some symptoms of attention-deficit hyperactivity disorder

European Psychiatry

Volumn 25, Issue 4, 2010, Pages 214-215

  Niederhofer, H ^a  

^a Regional Hospital Bozen   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; METHYLPHENIDATE; PLACEBO; DOPAMINE UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE;

ADOLESCENT; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CASE REPORT; ELECTROCARDIOGRAM; FEMALE; HUMAN; INSOMNIA; LABORATORY TEST; LETTER; PRIORITY JOURNAL; PULSE RATE; RATING SCALE; SIDE EFFECT; TREATMENT RESPONSE; WEIGHT REDUCTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TREATMENT OUTCOME;

EID: 77952427764     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.08.005     Document Type: Letter

References (15)

1. Biederman J., Baldessarini R.J., Wright V., Knee D., Harmatz J.S. A double-blind placebo controlled study of desipramine in the treatment of ADHD. I: efficacy. J Am Acad Child Adolesc Psychiatry 1989, 28:777-784.
2. Cohen D.J., Young J.G., Nathanson J.A., Shaywitz B.A. Clonidine in Tourette's syndrome. Lancet 1979, 2:551-553.
3. Crenshaw T.M., Kavale K.A., Forness S.R., Reeve R.E. Attention deficit hyperactivity disorder and the efficacy of stimulant medication: a meta-analysis. Advances in Learning and Behavioral Disabilities 1999, vol. 13:135-165. JAI Press, Greenwich, Conn. T.E. Scruggs, M.A. Mastropieri (Eds.).
4. DuPaul G.J., Anastopoulos A.D., MacGoey K.E., Power T.J., Reid R., Ikeda M.J. Teacher ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. Psychol Assess 1998, 9:436-444.
5. DuPaul G.J., Anastopoulos A.D., Power T.J., Reid R., Ikeda M.J., MacGoey K.E. Parent ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. J Psychopathol Behav Assess 1998, 20:57-81.
6. Greenhill L.L., Abikoff H.B., Arnold L.E., Cantwell D.P., Conners C.K., Elliott G., et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996, 35:1304-1313.
7. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989, 28:566-573.
8. Levine J., Schooler N. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986, 22:343-381.
9. Niederhofer H. Tianeptine as a slightly effective therapeutic option for attention-deficit hyperactivity disorder. Neuropsychobiology 2004, 49(3):130-133.
10. Rapport M.D., Denney C., DuPaul G.J., Gardner M.J. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 1994, 33:882-893.
11. Rosvold H.E., Mirsky A.F., Sarason I., Bransome E.D., Beck L.H. A continuous performance test of brain damage. J Consult Psychol 1956, 20:343-350.
12. Scahill L., Riddle M.A., McSwiggin-Hardin M., Ort S.I., King R.A., Goodman W.K., et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997, 36:844-852.
13. Singer H.S., Brown J., Quaskey S., Rosenberg L.A. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995, 95:74-81.
14. Swanson J.M., Wigal S., Greenhill L.L., Browne R., Waslik B., Lerner M., et al. Analog classroom assessment of ADHD in children with ADHD. J Am Acad Child Adolesc Psychiatry 1998, 37:519-526.
15. Wee S., Woolverton W.L. Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. Drug Alcohol Depend 2004, 75(3):271-276.